These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2989369)

  • 1. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
    Tosato G; Blaese RM; Yarchoan R
    J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA; Stein LD; Dosch HM; Sigal NH
    J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells.
    Stein LD; Ledgley CJ; Sigal NH
    J Immunol; 1983 Apr; 130(4):1640-5. PubMed ID: 6300231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
    Hibi T; Chan MA; Petsche D; Dosch HM
    J Immunol; 1986 May; 136(9):3211-8. PubMed ID: 3007613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ig isotypes produced by EBV-transformed B cells as a function of age and tissue distribution.
    Miyawaki T; Kubagawa H; Butler JL; Cooper MD
    J Immunol; 1988 Jun; 140(11):3887-92. PubMed ID: 2836502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limiting dilution analysis of the B cell compartment in human bone marrow.
    Hibi T; Dosch HM
    Eur J Immunol; 1986 Feb; 16(2):139-45. PubMed ID: 2869953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
    Conley ME; Chan MA; Sigal NH
    J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
    Straub C; Zubler RH
    J Immunol; 1989 Jan; 142(1):87-93. PubMed ID: 2535862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
    Brown NA; Miller G
    J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
    Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
    J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
    Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G; Magrath IT; Blaese RM
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production.
    Provvedini DM; Tsoukas CD; Deftos LJ; Manolagas SC
    J Immunol; 1986 Apr; 136(8):2734-40. PubMed ID: 3007606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.
    Maly FE; Cross AR; Jones OT; Wolf-Vorbeck G; Walker C; Dahinden CA; De Weck AL
    J Immunol; 1988 Apr; 140(7):2334-9. PubMed ID: 2832475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory functions of cultured human T lymphocytes.
    Uchiyama T; Broder S; Bonnard GD; Waldmann TA
    Trans Assoc Am Physicians; 1980; 93():251-62. PubMed ID: 6264658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotype commitment of human B cells that are transformed by Epstein-Barr virus.
    Miyawaki T; Butler JL; Radbruch A; Gartland GL; Cooper MD
    Eur J Immunol; 1991 Jan; 21(1):215-20. PubMed ID: 1846818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes.
    Gregory CD; Kirchgens C; Edwards CF; Young LS; Rowe M; Forster A; Rabbitts TH; Rickinson AB
    Eur J Immunol; 1987 Aug; 17(8):1199-207. PubMed ID: 3040424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.